MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with M

Methoxsalen

Methoxsalen 1.2% bath additive

No stability information

Stability notes for Methoxsalen 1.2% bath additive

There are no stability notes for this medicine.

Supplier

Methoxsalen 1.2% bath additive (Special Order)

Methoxsalen 10mg capsules

No stability information

Stability notes for Methoxsalen 10mg capsules

There are no stability notes for this medicine.

Supplier

8-MOP 10mg capsules (Imported (United States))

Methoxsalen 10mg tablets

No stability information

Stability notes for Methoxsalen 10mg tablets

There are no stability notes for this medicine.

Suppliers

Meladinine 10mg tablets (Imported (France))
Methoxsalen 10mg tablets (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.